Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolan Deng

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Molecules (Basel, Switzerland)|May 13, 2023
The Development of Naringin for Use against Bone and Cartilage DisordersJuwen Gan, Xiaolan Deng, Yonghong Le, et al.
Cancer Treatment and Research|December 19, 2023
RNA Modifications in Cancer Metabolism and Tumor MicroenvironmentYing Qing, Dong Wu, Xiaolan Deng, et al.
Clinical and Translational Medicine|September 5, 2023
The roles and therapeutic implications of messenger RNA internal N<sup>7</sup> -methylguanosine and N<sup>6</sup> -methyladenosine modifications in chemoresistanceZhicong Zhao, Ying Qing, Xiaolan Deng, et al.
Clinical and Translational Medicine|June 17, 2024
Meiling Chen, Yuanzhong Chen, Kitty Wang, et al.
Current Opinion in Genetics & Development|October 18, 2017
Role of N<sup>6</sup>-methyladenosine modification in cancerXiaolan Deng, Rui Su, Xuesong Feng, et al.
Trends in Cancer|March 29, 2022
FTO in cancer: functions, molecular mechanisms, and therapeutic implicationsYangchan Li, Rui Su, Xiaolan Deng, et al.
Cancer Cell|December 25, 2025
Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modificationsXiaolan Deng, Dong Wu, Yingqi Zhao, et al.
Cell Research|April 25, 2018
RNA N<sup>6</sup>-methyladenosine modification in cancers: current status and perspectivesXiaolan Deng, Rui Su, Hengyou Weng, et al.
Electrophoresis|November 20, 2012
Development of a CD-MEKC method for investigating the metabolism of tamoxifen by flavin-containing monooxygenases and the inhibitory effects of methimazole, nicotine and DMXAADuygu Yeniceli, Xiaolan Deng, Erwin Adams, et al.
Genes & Diseases|November 11, 2024
Prevalence of synonymous mutations in m<sup>6</sup>A modification sites in human cancersRichard Chen, Lu Yang, Li Han, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Molecules (Basel, Switzerland)|May 13, 2023
The Development of Naringin for Use against Bone and Cartilage DisordersJuwen Gan, Xiaolan Deng, Yonghong Le, et al.
Cancer Treatment and Research|December 19, 2023
RNA Modifications in Cancer Metabolism and Tumor MicroenvironmentYing Qing, Dong Wu, Xiaolan Deng, et al.
Clinical and Translational Medicine|September 5, 2023
The roles and therapeutic implications of messenger RNA internal N<sup>7</sup> -methylguanosine and N<sup>6</sup> -methyladenosine modifications in chemoresistanceZhicong Zhao, Ying Qing, Xiaolan Deng, et al.
Clinical and Translational Medicine|June 17, 2024
Meiling Chen, Yuanzhong Chen, Kitty Wang, et al.
Current Opinion in Genetics & Development|October 18, 2017
Role of N<sup>6</sup>-methyladenosine modification in cancerXiaolan Deng, Rui Su, Xuesong Feng, et al.
Trends in Cancer|March 29, 2022
FTO in cancer: functions, molecular mechanisms, and therapeutic implicationsYangchan Li, Rui Su, Xiaolan Deng, et al.
Cancer Cell|December 25, 2025
Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modificationsXiaolan Deng, Dong Wu, Yingqi Zhao, et al.
Cell Research|April 25, 2018
RNA N<sup>6</sup>-methyladenosine modification in cancers: current status and perspectivesXiaolan Deng, Rui Su, Hengyou Weng, et al.
Electrophoresis|November 20, 2012
Development of a CD-MEKC method for investigating the metabolism of tamoxifen by flavin-containing monooxygenases and the inhibitory effects of methimazole, nicotine and DMXAADuygu Yeniceli, Xiaolan Deng, Erwin Adams, et al.
Genes & Diseases|November 11, 2024
Prevalence of synonymous mutations in m<sup>6</sup>A modification sites in human cancersRichard Chen, Lu Yang, Li Han, et al.
Pageof 6